- Home
- ARWR vs TRIP Comparison
ARWR vs TRIP Comparison
Compare ARWR & TRIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- TRIP
- Stock Information
- Founded
- ARWR 2003
- TRIP 2000
- Country
- ARWR United States
- TRIP United States
- Employees
- ARWR N/A
- TRIP 2830
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- TRIP Computer Software: Programming Data Processing
- Sector
- ARWR Health Care
- TRIP Technology
- Exchange
- ARWR Nasdaq
- TRIP Nasdaq
- Market Cap
- ARWR 2.5B
- TRIP 1.8B
- IPO Year
- ARWR 1993
- TRIP 2011
- Fundamental
- Price
- ARWR $36.64
- TRIP $15.52
- Analyst Decision
- ARWR Strong Buy
- TRIP Hold
- Analyst Count
- ARWR 8
- TRIP 9
- Target Price
- ARWR $47.75
- TRIP $17.03
- AVG Volume (30 Days)
- ARWR 2.4M
- TRIP 2.9M
- Earning Date
- ARWR 11-25-2025
- TRIP 11-05-2025
- Dividend Yield
- ARWR N/A
- TRIP N/A
- EPS Growth
- ARWR N/A
- TRIP 165.58
- EPS
- ARWR N/A
- TRIP 0.46
- Revenue
- ARWR $572,976,000.00
- TRIP $1,870,000,000.00
- Revenue This Year
- ARWR $21,421.26
- TRIP $7.41
- Revenue Next Year
- ARWR N/A
- TRIP $7.26
- P/E Ratio
- ARWR N/A
- TRIP $33.88
- Revenue Growth
- ARWR 2816.20
- TRIP 3.03
- 52 Week Low
- ARWR $9.57
- TRIP $10.43
- 52 Week High
- ARWR $39.42
- TRIP $20.16
- Technical
- Relative Strength Index (RSI)
- ARWR 73.44
- TRIP 36.45
- Support Level
- ARWR $36.29
- TRIP $15.40
- Resistance Level
- ARWR $39.38
- TRIP $17.03
- Average True Range (ATR)
- ARWR 1.39
- TRIP 0.85
- MACD
- ARWR 0.06
- TRIP -0.25
- Stochastic Oscillator
- ARWR 69.44
- TRIP 4.12
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About TRIP TripAdvisor Inc.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2024, 52% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of sales in 2024, and TheFork, its dining brand, represented 10% of revenue (about 8% of sales were intersegment, which are eliminated from consolidated revenue).